Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Silvia Noventa
Observed names:
Noventa, S.,
S. Noventa
Institution:
Fondazione Poliambulanza Istituto Ospedaliero
Observed institutions:
University of Modena and Reggio Emilia,
Azienda Ospedaliero-Universitaria di Modena,
Fondazione Poliambulanza Istituto Ospedaliero
ORCID:
0000-0001-7423-6065
Observed ORCID:
0000-0001-7423-6065
OpenAlex ID:
A5048453573
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients
2016
·
C. Omarini
, G. Guaitoli
, et al.
·
European Journal of Surgical Oncology
·
66
Trifluridine/Tipiracil (TAS-102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program
2018
·
Chiara Cremolini
, Daniele Rossini
, et al.
·
The Oncologist
·
61
PDF
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey
2021
·
G. Orsi
, M. Di Marco
, et al.
·
ESMO Open
·
24
PDF
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer – A GISCAD phase II randomized trial
2021
·
Stefano Cascinu
, Rossana Berardi
, et al.
·
European Journal of Cancer
·
21
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma
2023
·
Letizia Procaccio
, Valeria Merz
, et al.
·
Cancer Medicine
·
18
PDF
Microsatellite instability and chemosensitivity in solid tumours
2022
·
Sara Cherri
, Ester Oneda
, et al.
·
Therapeutic Advances in Medical Oncology
·
18
PDF
Impact of a Psycho-Educational Team in early Breast Cancer Patients’ Coping Strategies: The Venere Project
2018
·
Federica Andreis
, Fausto Meriggi
, et al.
·
Reviews on Recent Clinical Trials
·
16
Pancreatic adenocarcinoma: Beyond first line, where are we?
2021
·
Sara Cherri
, Silvia Noventa
, et al.
·
World Journal of Gastroenterology
·
14
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram
2018
·
Filippo Pietrantonio
, Francesco Barretta
, et al.
·
Oncology
·
14
PDF
Role of diet, physical activity and new drugs in the primary management of cancer cachexia in gastrointestinal tumors – a comprehensive review
2025
·
Ester Oneda
, Alessandra Manno
, et al.
·
Frontiers in Oncology
·
13
PDF
Drug-Related Pneumonitis in Cancer Treatment during the COVID-19 Era
2021
·
Sara Cherri
, Silvia Noventa
, et al.
·
Cancers
·
13
PDF
Neuroendocrine differentiation in castration resistant prostate cancer. Nuclear medicine radiopharmaceuticals and imaging techniques: A narrative review
2019
·
Sharjeel Usmani
, Marina Orevi
, et al.
·
Critical Reviews in Oncology/Hematology
·
13
Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab ‐paclitaxel plus gemcitabine as second or later‐line treatment
2024
·
Guido Giordano
, Michele Milella
, et al.
·
Cancer Medicine
·
11
What Is Next for Refractory Colorectal Cancer CRC? Looking Beyond SUNLIGHT, FRESCO2, RECURSE and CORRECT
2025
·
Sara Cherri
, Michela Libertini
, et al.
·
International Journal of Molecular Sciences
·
9
Multicenter phase I/II trial of gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer
2024
·
Tiziana Pressiani
, Rita Balsano
, et al.
·
European Journal of Cancer
·
8
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv)
2022
·
Giulia Orsi
, Alessandro Cavaliere
, et al.
·
British Journal of Cancer
·
8
Yoga Protocol for Cancer Patients: A Systematic Exploration of Psychophysiological Benefits
2019
·
Mara Mirandola
, Miguel David Sabogal Rueda
, et al.
·
Reviews on Recent Clinical Trials
·
6
Depression as a Prodromal Symptom of Pancreatic Cancer: A Narrative Review
2025
·
Chiara Deori
, Federica Andreis
, et al.
·
Cancers
·
5
PDF
Training gut and body: physical activity, diet, ASA and microbiota influence the outcome in gastrointestinal cancer survivors
2025
·
Ester Oneda
, Silvia Noventa
, et al.
·
Frontiers in Nutrition
·
4
PDF
Real‐World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1 ‐2 Pathogenic Variants
2025
·
Michele Milella
, Giulia Orsi
, et al.
·
Cancer Medicine
·
4
Chemotherapy in advanced pancreatic cancer with hyperbilirubinemia
2020
·
Silvia Noventa
, Sara Cherri
, et al.
·
Digestive Medicine Research
·
4
Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency?
2020
·
Sara Cherri
, Silvia Noventa
, et al.
·
Medical Hypotheses
·
4
PDF
Observational retrospective evaluation of treatment with liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic cancer patients: An Italian large real-world analysis.
2020
·
Antonio Pellino
, Chiara Manai
, et al.
·
Journal of Clinical Oncology
·
4
Outcome of oncological patients admitted with COVID-19: experience of a hospital center in northern Italy
2020
·
Sara Cherri
, Daniel H. L. Lemmers
, et al.
·
Therapeutic Advances in Medical Oncology
·
4
Nab-paclitaxel (Nab) plus gemcitabine (G) is more effective than G alone in locally advanced, unresectable pancreatic cancer (LAUPC): The GAP trial, a GISCAD phase II comparative randomized trial
2019
·
S. Cascinu
, R. Berardi
, et al.
·
Annals of Oncology
·
4
Show more works
View as search
Works count:
50
Citation count:
376
H-index:
12
I10-index:
13
Year
Topic
Type